[151]
Optimal therapy for patients with high-risk superficial bladder ...
[502,3 KB]
From [www.immucyst.com] Last viewed: 07.09.2006
Abstract. Chromosomal aneuploidy is associated with invasive
bladder cancer and one of the genes implicated in these
changes is Aurora-A/STK15/BTAK, that is localized on
chromosome 20q13 and encodes a centrosome-associated
serine/threonine kinase. To better understand the association
between Aurora-A/STK15 expression, tumor aneuploidy
and clinical prognosis, we sought to determine whether
overexpression of Aurora-A/STK15 in cultured urothelial
cells facilitated chromosomal instability. Using immuno-
fluorescence staining, Northern and Western blot analyses,
we verified that overexpression of Aurora-A/STK15 in
bladder tumor cell lines enhanced chromosomal instability.
Additionally, we observed that some bladder tumor cell
lines expressed more Aurora-A/STK15 than cultured normal
urothelial cells and that Aurora-A/STK15 expression was
higher in an immortalized E7 urothelial cell line having 20q ...
[152]
375 Early detection of bladder cancer in hematuria patients ...
[1027,9 KB]
From [www.adl.de] Last viewed: 07.09.2006
375
Early detection of bladder cancer in hematuria
patients: Vision becomes reality
P. Oehr , University Bonn, Germany.
Conclusions
The superior sensitivity of
NMP22-BladderChek® over
cytology, at the specificity of
98%, and the negative predictive
value of 98%, give reason to call
it an easy to handle cancer
screening assay.
Combined use with cytology can
result in a highly reliable
screening: under the condition
"both test are positive", no false
positive results arose, making
this assumption a 100% tumor
inclusion criterion in 67% of the
patients who had developed a
yet undetected urinary bladder
cancer .
In addition, a negative predictive
value of 98% for
NMP22-BladderChek® is an
excellent exclusion criterion.
Independently,
NMP22-BladderChek® can detect
82% to 86% urinary bladder
cancer ...
[153]
Case-Control Study of Bladder Cancer and Exposure to Arsenic in ...
[117,5 KB]
From [www.ruralwater.org] Last viewed: 07.09.2006
381
Am J Epidemiol 2004;159:381–389
American Journal of Epidemiology
Copyright © 2004 by the Johns Hopkins Bloomberg School of Public Health
All rights reserved
Vol. 159, No. 4
Printed in U.S.A.
DOI: 10.1093/aje/kwh054
Case-Control Study of Bladder Cancer and Exposure to Arsenic in Argentina
Michael N. Bates
1
, Omar A. Rey
2
, Mary L. Biggs
3
, Claudia Hopenhayn
4
, Lee E. Moore
5
, David
Kalman
6
, Craig Steinmaus
1
, and Allan H. Smith
1
1
Arsenic Health Effects Research Group, School of Public Health, University of California, Berkeley, CA.
2
Facultad de Medicina, Universidad Catolica de Córdoba, Córdoba, Argentina.
3
Arsenic Health Effects Research Group, School of Public Health, ...
[154]
Possible distinct molecular carcinogenic pathways for bladder ...
[37,7 KB]
From [147.52.72.117] Last viewed: 07.09.2006
Abstract. After the Chernobyl accident in 1986, the incidence
of urinary bladder cancers in the Ukraine increased gradually
from 26.2 to 43.3 per 100,000 people between 1986 and 2001.
In the areas of low level but persistent cesium-137 (
137
Cs)
radio-contamination, a unique atypical radiation-related urinary
bladder cystitis named ‘Chernobyl cystitis’, a possible pre-
neoplastic condition in humans, has been detected. We have
previously documented high incidences of bladder lesions,
including severe dysplasias and/or carcinoma in situ , in
association with this cystitis and correlating with oxidative
DNA damage. To further investigate the molecular mechanisms
underlying bladder carcinogenesis with this specific etiology,
mutation analysis of p53 gene (exon 5-8) was performed for
11 and 18 paraffin-embedded bladder cancers in Ukrainians,
respectively collected before and after ...
[155]
Telomere Length Analysis as a Novel Diagnostic Test for Bladder Cancer
[200,0 KB]
From [www.ualberta.ca] Last viewed: 07.09.2006
Enquiries Journal of Interdisciplinary Studies for High School Students
Vol. 1, No. 1. pp. 6 - 9, 2003
Salivary Cortisol Levels and Aging
by Christa Preuss
Research Mentors: Dr. Kathleen Hegadoren, Saskia de Jager Burford (University of Alberta,
Edmonton, Alberta)
The purpose of this study was to determine if saliva samples collected from Alzheimer’s
patients offered a feasible method for testing cortisol levels. Five patients, with a mean age of 88
years old, and a male-female ratio of 1:4, had their saliva samples taken four times throughout the
day, 0800h, 1200h, 1600h and 2000h. Salivary ELISA kits and a spectrophotometer were used to
detect the cortisol levels in the samples. This data was compared to daytime cortisol levels of a
healthy 17-year old female, in follicular phase, in order to differentiate age-related differences. The
general trend of the cortisol patterns seemed ...
[156]
Case-Control Study of Bladder Cancer and Exposure to Arsenic in ...
[113,1 KB]
From [socrates.berkeley.edu] Last viewed: 07.09.2006
381
Am J Epidemiol 2004;159:381–389
American Journal of Epidemiology
Copyright © 2004 by the Johns Hopkins Bloomberg School of Public Health
All rights reserved
Vol. 159, No. 4
Printed in U.S.A.
DOI: 10.1093/aje/kwh054
Case-Control Study of Bladder Cancer and Exposure to Arsenic in Argentina
Michael N. Bates
1
, Omar A. Rey
2
, Mary L. Biggs
3
, Claudia Hopenhayn
4
, Lee E. Moore
5
, David
Kalman
6
, Craig Steinmaus
1
, and Allan H. Smith
1
1
Arsenic Health Effects Research Group, School of Public Health, University of California, Berkeley, CA.
2
Facultad de Medicina, Universidad Catolica de Córdoba, Córdoba, Argentina.
3
Arsenic Health Effects Research Group, School of Public Health, ...
[157]
Arsenic-Related Chromosomal Alterations in Bladder Cancer
[98,9 KB]
From [socrates.berkeley.edu] Last viewed: 07.09.2006
Arsenic-Related Chromosomal Alterations in
Bladder Cancer
Lee E. Moore, Allan H. Smith, Clarence Eng, David Kalman, Sandy DeVries,
Vivek Bhargava, Karen Chew, Dan Moore II, Catterina Ferreccio, Omar A. Rey,
Frederic M. Waldman
Background: Previous studies have demonstrated that inges-
tion of arsenic in drinking water is a strong risk factor for
several forms of cancer , including bladder cancer . It is not
known whether arsenic-related cancers are genetically simi-
lar to cancers in unexposed individuals or what mechanisms
of carcinogenesis may underlie their formation. This study
was designed to compare chromosomal alterations in blad-
der cancers of arsenic-exposed individuals to provide insight
into the mechanism of how arsenic may induce or promote
cancer . Methods: A case–case study was conducted in Ar-
gentina and Chile examining chromosomal ...
[158]
MD ANDERSON CANCER CENTER BLADDER CANCER TISSUE BANK Specimen ...
[39,9 KB]
From [www.mdanderson.org] Last viewed: 07.09.2006
M. D. ANDERSON CANCER CENTER
BLADDER CANCER TISSUE BANK
Specimen Request Form (Page 1 of 5)
Date of request:
Date needed:
Investigator:
Email:
Department:
Phone:
Beeper:
Fax:
Collaborators
Department
Contact Person
Phone:
Beeper:
Location:
Title of Project:
Objectives of Project:
The tissue requested will be used for
(please provide brief description to aid in the selection of samples)
:
Source of Funding
NIH
ACS
DOD
None
Other: (specify):
Non-NIH peer reviewed
Non-peer reviewed
The results obtained from the study of the requested tissue samples will:
a) Only be correlated with the grade and stage:
Yes
No
Other
b) Will require patients’ identity:
Yes
No
Other
Do you have institutional approval for this project:
...
[159]
BLADDER CANCER ICD-O-C67 TNM CLASSIFICATION T Primary tumour TX ...
[75,9 KB]
From [www.moh.gov.ae] Last viewed: 07.09.2006
BLADDER CANCER
ICD-O-C67
TNM CLASSIFICATION
T Primary tumour
TX Primary tumour has not been assessed
T0 No primary tumour seen
Tis Non-papillary, non-invasive
Ta Non-invasive papillary carcinoma
T1 Tumour invades subepithelial connective tissue
T2 Tumour invades superficial muscle (inner half)
T3 Tumour invades deep muscle or perivesical fat
T3a Tumour invades deep muscle (outer half)
T3b Tumour invades perivesical fat
T4 Tumour invades any of the following: prostate, uterus, vagina, pelvic wall
abdominal wall
N Regional lymph nodes
NX Regional lymph nodes have not been assessed
N0 No regional lymph node metastases
N1 Regional metastatic lymph nodes, diameter < 2 cm
N2 Regional lymph node metastases, 2 - 5 cm in diameter, or multiple nodes with
diameter
< 5 cm
N3 Regional metastatic nodes > 5cm in diameter
M Distant metastases ...
[160]
Case-Control Study of Bladder Cancer and Drinking Water Arsenic in ...
[112,0 KB]
From [socrates.berkeley.edu] Last viewed: 07.09.2006
1193
Am J Epidemiol 2003;158:1193–1201
American Journal of Epidemiology
Copyright © 2003 by the Johns Hopkins Bloomberg School of Public Health
All rights reserved
Vol. 158, No. 12
Printed in U.S.A.
DOI: 10.1093/aje/kwg281
Case-Control Study of Bladder Cancer and Drinking Water Arsenic in the Western
United States
Craig Steinmaus
1
, Yan Yuan
2
, Michael N. Bates
2
, and Allan H. Smith
2
1
Division of Occupational and Environmental Medicine, University of California, San Francisco, CA.
2
School of Public Health, University of California, Berkeley, CA.
Received for publication November 13, 2002; accepted for publication June 23, 2003.
Numerous epidemiologic investigations have identified links between high concentrations of arsenic in drinking
water and cancer , although the ...
[161]
Treatment of Superficial Bladder Cancer
[366,4 KB]
From [www.touchbriefings.com] Last viewed: 07.09.2006
Dr Willem Oosterlinck is currently
Chairman of the Superficial Bladder
Cancer Committee of the European
Organisation for Research and
Treatment of Cancer (EORTC) and
heads the Department of Urology
at the University Hospital Ghent in
Belgium. Formerly President of the
Belgian Society of Urology (BVU)
and the Belgian Congress of
Urology, he is currently a member
of the Accreditation Commission for
Urology of the Ministry of Health,
the European Urological Association
(EAU), The Société Internationale
d’Urologie (SIU) and BVU. Dr
Oosterlinck was also Chairman of
the committee responsible for
development of guidelines on
superficial bladder tumours in the
EAU. He began his career at the
University Hospital Ghent as a
Senior Assistant in Urology and
advanced to Adjunct Director of the
Department of Urology, prior to
earning his current position. Dr ...
[162]
Telomere Length Analysis as a Novel Diagnostic Test for Bladder Cancer
[313,5 KB]
From [www.ualberta.ca] Last viewed: 07.09.2006
Enquiries Journal of Interdisciplinary Studies for High School Students
Vol. 1, No. 1. pp. 1 - 5, 2003
Telomere Length Analysis as a Novel Diagnostic Test for Bladder Cancer
by Sabira Suleman
Research Mentors: Erik Johnson, Dr. Johnathan Lakey. Shaheed Merani, Dr. Ronald Moore, and
Annie Young (University of Alberta, Edmonton, Alberta)
Superficial bladder cancer , diagnosed in 5000 new cases in Canada yearly, is both common
and has a high recurrence rate, which creates the necessity for an efficient and rapid method of tumor
surveillance. Although telomere length in cancer cells is relatively shorter than normal somatic cells
due to unlimited proliferation, cancer cells remain mitotic due to telomerase activation. Telomerase
is a reverse transcriptase enzyme (hTERT) that is present in many different malignancies.
Maintaining telomeric stability via telomerase expression is the ...
[163]
Information for patients with bladder cancer
[77,8 KB]
From [www.somerset.nhs.uk] Last viewed: 07.09.2006
Leaflet No 8601500
04/03/98 BCa 1
Reviewed 2/03
Information for
patients with
bladder cancer
Urology Department
Information prepared by
Mrs Sue Cumisky
Nurse Practitioner Urology
East Somerset NHS Trust
(01935) 384394
Further information for people with
cancer is available on request or
may be obtained by contacting:
Macmillan cancer relief
0845 6016161
or
CancerBACUP
0800 18 11 99
Page 2
Bladder cancer treatment
Information gained from looking at the tumour
under the microscope suggests that further
treatment is needed.
In some cases the cancer has developed
deeper roots invading the bladder wall
making more radical treatment with surgery
or radiotherapy necessary.
The treatments are generally equally
effective, the aim being to eradicate the
...
[164]
Information for patients with newly diagnosed bladder cancer
[75,9 KB]
From [www.somerset.nhs.uk] Last viewed: 07.09.2006
Leaflet No 8601601
04/03/98 NBCA 1
Reviewed 2/03
Information for
patients with
newly diagnosed
bladder cancer
Urology Department
Information prepared by
Mrs Sue Cumisky
Nurse Practitioner Urology
East Somerset NHS Trust
(01935) 384394
Further information for people with
cancer is available on request or
may be obtained by contacting:
Macmillan cancer relief
0845 6016161
or
CancerBACUP
0800 18 11 99
Page 2
At your cystoscopy today, a growth has been
found which is likely to be malignant ( cancer ).
Bladder cancers grow like warts on the lining
of the bladder . As they develop, they can put
down deeper roots which may affect the
muscular wall of the bladder . In the early
stages, the cancer is easy to treat and the
condition can be monitored by regular
examinations ...
[165]
BCG plus Interferon-alpha for Superficial Bladder Cancer
[1087,5 KB]
From [www.uihealthcare.com] Last viewed: 07.09.2006
Enquiries Journal of Interdisciplinary Studies for High School Students
Vol. 1, No. 1. pp. 1 - 5, 2003
Telomere Length Analysis as a Novel Diagnostic Test for Bladder Cancer
by Sabira Suleman
Research Mentors: Erik Johnson, Dr. Johnathan Lakey. Shaheed Merani, Dr. Ronald Moore, and
Annie Young (University of Alberta, Edmonton, Alberta)
Superficial bladder cancer , diagnosed in 5000 new cases in Canada yearly, is both common
and has a high recurrence rate, which creates the necessity for an efficient and rapid method of tumor
surveillance. Although telomere length in cancer cells is relatively shorter than normal somatic cells
due to unlimited proliferation, cancer cells remain mitotic due to telomerase activation. Telomerase
is a reverse transcriptase enzyme (hTERT) that is present in many different malignancies.
Maintaining telomeric stability via telomerase expression is the ...
[166]
Novel photodynamic diagnosis of bladder cancer: Ex vivo ...
[133,1 KB]
From [histology1.med.uoc.gr] Last viewed: 07.09.2006
Abstract. In this study we have evaluated the use of hypericin
ex vivo urine fluorescence cytology as a non-invasive method
for detecting early bladder cancers. To date this is the first
study reported using this technique with hypericin. Urine
samples from patients with early bladder cancers were
processed for fluorescence cytology by incubation with
hypericin, a novel photosensitizer. Normal urine samples
incubated with hypericin served as normal controls. Laser
confocal microscopy and spectroscopy was used to detect the
fluorescence in the exfoliated low-grade urothelial tumor cells.
Fluorescence cytology was considered positive if hypericin
fluorescence of the low-grade urothelial tumor cells was
detected to be stronger (>8.5 times) compared to the baseline
fluorescence established for normal urine samples. Automated
analysis for an objective reproducible outcome appears
possible. The ...
[167]
Bladder Cancer - Cancer survival, incidence and mortality in NSW ...
[134,8 KB]
From [www.cancercouncil.com.au] Last viewed: 07.09.2006
Bladder
Cancer survival, incidence and mortality in NSW 1994–2000
50
The Cancer Council NSW
Bladder cancer
• The five-year relative survival from bladder cancer in NSW between 1994 and 2000 was
62.0%
• No Area Health Service was different from the State average in the adjusted relative risk
of excess death after shrinking
• An additional 52 patients would be expected to survive to five years after diagnosis in
NSW if the State average risk was shifted to the 20
th
centile of the distribution
• There were 3,784 new cases of bladder cancer in NSW in 1994 to 1998 (2,769 males and
1,015 females) and 1,353 deaths (965 males and 388 females)
• There were 29 more new cases of bladder cancer in males than expected in Central
Coast and 33 fewer than expected in Northern Sydney
• There were no Area Health Services in which the number of new cases of bladder ...
[168]
Macro-microscopic fluorescence of human bladder cancer using ...
[299,2 KB]
From [147.52.72.117] Last viewed: 07.09.2006
Abstract. The early detection of carcinoma is very essential
for the diagnosis and prognosis of a bladder cancer patient. In
this study we have investigated the use of hypericin as a
fluorescent tumour marker and laser confocal microscopy as
a diagnostic tool to aid the diagnosis of such cancers. Both
cellular and clinical studies have been conducted. In the
cellular studies, we have compared two bladder cell lines
for the uptake and sub-cellular localization of hypericin. It
was found that there was a rapid uptake and clearance of
hypericin and significant localization in mitochondria and
lysosomes. The study also revealed that there was a time-
dependent increase in fluorescence intensity in bladder cells.
The optimum localization was found to be 2-4 h post drug
incubation. In the clinical study, consisting of 30 patients,
both white light and fluorescence cystoscopy were
performed after ...
[169]
Cystoscopic Diagnosis of Bladder Cancer by Intravesical ...
[6,0 KB]
From [www.annals.edu.sg] Last viewed: 07.09.2006
March 2000, Vol. 29 No. 2
153
Fluorescence Diagnosis of Bladder Cancer after 5-ALA—W Lau et al
Cystoscopic Diagnosis of Bladder Cancer by Intravesical Instillation of 5-
Aminolevulinic Acid Induced Porphyrin Fluorescence—The Singapore Experience
C W S Cheng,*
FAMS, MBBS, FRCS (Edin & Glas)
, W K O Lau,**
MBBS, M Med, FRCS
, P H Tan,***
FAMS, MBBS, FRCPA
, M Olivo,****
PhD, BSc, BEd
Abstract
Objectives: 1) To determine whether fluorescence cystoscopy after intravesical administration of 5-aminolevulinic acid (5-ALA) is more
sensitive in detection of dysplasia and bladder cancer when compared with conventional cystoscopy. 2) To determine the safety of using 5-
ALA. Materials and Methods: A 3% 5-ALA solution was instilled intravesically before cystoscopy in 41 patients. The 5-ALA-induced
porphyrin fluorescence ...
[170]
N-acetyltransferase 2 Phenotype in Painters with Bladder Cancer ...
[4,6 KB]
From [www.annals.edu.sg] Last viewed: 07.09.2006
464
Annals Academy of Medicine
NAT2 Phenotype in Painters—K Golka et al
N-acetyltransferase 2 Phenotype in Painters with Bladder Cancer and Controls
K Golka,*
MD
, W Weistenhöfer,**
MD
, P Jedrusik,**
MD
, F Geller,***
MSc
, M Blaszkewicz,
+
PhD
, H M Bolt,
++
MD, PhD
Abstract
Aim: This study was designed to evaluate the impact of N-acetyltransferase 2 (NAT2, substrate: aromatic amines) in painters with bladder
cancer and controls. Background: Until the beginning of the 1960s, painters in Germany have used, among others, azo dyes based on
carcinogenic aromatic amines. Materials and Methods: Sixteen painters with bladder cancer and 26 healthy painters (controls) who were
from the same areas in Germany and in the same age group (± 5 years) were recruited into ...
[171]
Bladder Cancer Recurrence Kit
[59,4 KB]
From [www.vysis.com] Last viewed: 07.09.2006
CEP
®
3 SpectrumRed
™
, CEP 7 SpectrumGreen
™
, CEP 17 SpectrumAqua
™
and LSI
®
p16
(9p21) SpectrumGold
™
Bladder Cancer Recurrence Kit for Aneuploidy Detection of
Chromosomes 3, 7 and 17 and Deletion of p16 (9p21).
Figure 1: A diagram of the 9p21 region and sequence tagged sites (STS) known to be contained
within this region. The yellow bar represents the approximately 220 kb region covered by the LSI
p16 (9p21) probe. Map not to scale.
Figure 2: Normal result observed in an interphase cell
obtained from a sample after the Vysis
®
UroVysion
probe hybridization. Each probe signal; CEP 3 (red),
CEP 7 (green), CEP 17 (aqua) and LSI p16 (gold)
is present in two copies.
Figure 3: Aneusomic interphase cell obtained from a
sample showing two copies of chromosome 3 ...
[172]
Post Operative Radiotherapy in Bladder Cancer
[119,9 KB]
From [www.nci.edu.eg] Last viewed: 07.09.2006
Journal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 3, September: 137-144, 2004
Predictors of Outcome after Radical Cystectomy for Bladder
Cancer in Saudi Patients; Single Institution Experience
ALAA A. MOKHTAR, M.D.*; MEDHAT M. EL-SEBAIE, M.D.** and NASER ELKUM, Ph.D.***
The Departments of Urology*, Oncology** and Biostatistics, Epidemiology & Scientific Computing***, King Faisal
Specialist Hospital and Research Centre, Riyadh, KSA.
ABSTRACT
Aim of the Study: To evaluate different prognostic
factors that may affect disease-specific survival in patients
with bladder cancer following radical cystectomy.
Methods: Between July 1975 and December 2000,
229 patients underwent radical cystectomy and urinary
diversion for bladder cancer in King Faisal Specialist
Hospital and Research Center (KFSH & RC), Riyadh,
Saudi Arabia. 175 patients had available ...
[173]
Bladder Cancer and Exposure to Ionizing Radiation Summary ...
[25,8 KB]
From [www.mtafund.org] Last viewed: 07.09.2006
Center for Environmental Health Studies
(617) 482-9485
44 Farnsworth Street, Boston, MA 02210
http://www.jsi.com
*
Findings were statistically significant (strong evidence)
+
Evidence of a dose-response relationship (strongest evidence)
Page 13
Bladder Cancer and
Exposure to Ionizing Radiation
Summary:
There is strong evidence that bladder cancer may be associated with exposure to
ionizing radiation. This evidence includes studies of nuclear workers. This is consistent with the
National Research Council’s finding that the bladder is sensitive to ionizing radiation. Bladder
cancer is designated as a “specified” cancer under the Energy Employees Occupational Illness
Compensation Program Act. Historically, incidence of bladder cancer has been high in both Los
Alamos County and Rio Arriba County. Mortality has been very ...
[174]
12. Urinary Bladder Cancer
[323,1 KB]
From [www.sbu.se] Last viewed: 07.09.2006
Journal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 3, September: 137-144, 2004
Predictors of Outcome after Radical Cystectomy for Bladder
Cancer in Saudi Patients; Single Institution Experience
ALAA A. MOKHTAR, M.D.*; MEDHAT M. EL-SEBAIE, M.D.** and NASER ELKUM, Ph.D.***
The Departments of Urology*, Oncology** and Biostatistics, Epidemiology & Scientific Computing***, King Faisal
Specialist Hospital and Research Centre, Riyadh, KSA.
ABSTRACT
Aim of the Study: To evaluate different prognostic
factors that may affect disease-specific survival in patients
with bladder cancer following radical cystectomy.
Methods: Between July 1975 and December 2000,
229 patients underwent radical cystectomy and urinary
diversion for bladder cancer in King Faisal Specialist
Hospital and Research Center (KFSH & RC), Riyadh,
Saudi Arabia. 175 patients had available ...
[175]
A study comparing various noninvasive methods of detecting bladder ...
[8,0 KB]
From [www.adl.de] Last viewed: 07.09.2006
A study comparing various noninvasive methods of detecting
bladder cancer in urine.
Saad, A.; Hanbury, D. C.; McNicholas, T. A.; Boustead, G. B.; Morgan, S.; Woodman, A. C.
JOURNAL NAME: BJU International : Volume 89, Issue 4, March 2002, PP. 369-73
CORPORATE AUTHOR-
Department of Urology, Lister Hospital, Stevenage, and Cranfield BioMedical Centre,
Institute of BioScience and Technology, Cranfield University at Silsoe, UK.
Objectives To compare the nuclear matrix protein (NMP)-22 assay, bladder tumour specific
antigen (BTAstat) test, telomerase activity (using the telomeric repeat amplification protocol
assay, TRAP) and a haemoglobin dipstick test for their ability to replace voided urine
cytology (VUC) for detecting bladder cancer .
Patients and methods The study included 120 urological patients prospectively recruited and
assessed before surgery. A single freshly voided urine sample ...
[176]
Breakthrough bladder cancer test: Physician, patient access ...
[14,4 KB]
From [www.advamed.org] Last viewed: 07.09.2006
Breakthrough bladder cancer test:
Physician, patient access stymied by Medicare
This year about 60,000 people will be diagnosed with bladder cancer and about 12,400
people will die of this disease, the American Cancer Society estimates. Bladder cancer is the
fourth most common cancer among men and the eighth most common among women. Most
people found to have bladder cancer are in their late 60s, according to the ACS, meaning
they are covered under Medicare.
A breakthrough diagnostic lab test, which was named the most innovative product of 1999 by
Medical Device and Diagnostic Industry magazine, allows physicians to conveniently perform
bladder cancer testing directly in their offices to monitor progression of the disease and
quickly detect recurrence. Doctors also can prescribe the test for use at home by the patient.
However, long Medicare delays in establishing proper coding and reimbursement ...
[177]
Apoptosis of bladder cancer cells induced by short-term and low ...
[190,1 KB]
From [147.52.72.117] Last viewed: 07.09.2006
Abstract. Adjuvant chemotherapies have been used to prevent
recurrence of bladder transitional cell carcinoma (TCC),
but their efficacies are variable due to the side effects of anti-
cancer agents and the drug resistant property of the target
cells. To provide experimental evidence for improving
clinical management of TCCs, two human TCC cell lines,
EJ and BIU, were treated for 1 or 2 h by 50, 100, 150 and
200 µ g/ml, respectively and their growth and death patterns
were elucidated in 12-h intervals. The status of Fas, FasL and
caspase-3 in the two cell lines were analyzed with immuno-
cytochemical staining and Western blot hybridization, and
their potential link to MMC-induced cell death was investigated
by treating the cells with anti-Fas antibody (150 ng/ml) and
by incubating the cells with an inhibitor of caspase-3 related
proteases Ac-DEVO-CHO (250 µ M) 1 h before 100 µ g/ml
MMC treatment. ...
[178]
Fluorescence confocal microscopy and image analysis of bladder ...
[345,5 KB]
From [histology1.med.uoc.gr] Last viewed: 07.09.2006
Abstract. 5-Aminolevulinic acid mediated changes in tissue
specific fluorescence were studied in bladder cancer .
Bladders of normal patients and also patients diagnosed with
cancer were instilled with 5-aminolevulinic acid and the
resultant protoporphyrin IX mediated fluorescence intensity
was imaged and quantified with confocal laser microscopy
and fluorescence image analysis. Urothelial tumour cells were
observed to fluoresce more intensely than normal urothelial
cells. Submucosa and muscle tissues exhibited minimal
fluorescence compared to urothelial cells of malignant origin
and also normal urothelial cells. Degree of fluorescence
intensity was in the order of malignant urothelium > normal
urothelium > normal submucosa > normal muscles. Fluore-
scence intensity was also found to increase with duration of
ALA instillation. Grade 3 malignant cells produced more
fluorescence compared ...
[179]
Entering the unresolved debate between alcohol consumption and ...
[86,3 KB]
From [www.studentbmj.com] Last viewed: 07.09.2006
Entering the unresolved debate between
alcohol consumption and bladder cancer ,
epidemiologists analysed data from an
Italian case-control study and concluded
that even in populations that drink a lot (in
this case, wine) there is no significant associ-
ation between the two. It’s possible that con-
founding factors such as smoking, coffee
drinking, and occupation (allowed for in this
analysis) may have given rise to earlier
inconsistent results ( Journal of Clinical Epi-
demiology 2002;55:637-41).
Summer sunburn seems to be the norm
among American teenagers despite high
sunscreen use. With 72% of teenagers ex-
periencing at least one sunburn during the
summer, public health campaigns should
probably be paying more attention to
getting the message across about hat
wearing, protective clothing, and avoiding
peak exposure times in the war against skin
cancer ( Pediatrics ...
[180]
URINARY BLADDER CANCER STAGE FORM
[52,9 KB]
From [www.stonybrookhospital.com] Last viewed: 07.09.2006
STATE UNIVERSITY OF NEW YORK
UNIVERSITY HOSPITAL AND
MEDICAL CENTER
URINARY BLADDER
CANCER STAGE FORM
Type of specimen __
Histopathologic Type __
Tumor Size _
SIDE 1 OF 2
TU2C012 (9/02)
Patient Name _
Date of Birth __
MR# __
Enc# __
Sex
Race __
Pt Type: § In § Out § E.D
Clin
Path
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
Clin
Path
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
DEFINITIONS ...